David Nash

David Nash is the founding dean of the Jefferson School of Population Health (JSPH) of Thomas Jefferson University and the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy in Philadelphia. JSPH provides innovative educational programming designed to develop healthcare leaders for the future. Its offerings include masters programs in public health, healthcare quality and safety, health policy, and applied health economics. JSPH also offers a doctoral program in population health science.

Dr. Nash is a board-certified internist who is internationally recognized for his work in outcomes management, medical staff development, and quality of care improvement. In 1995, he was awarded the Latiolais Prize by the Academy of Managed Care Pharmacy. He received the Philadelphia Business Journal Healthcare Heroes Award in October 1997 and was named an honorary distinguished fellow of the American College of Physician Executives in 1998. In 2006, he received the Elliot Stone Award for leadership in public accountability for health data from NAHDO. In 2009, Dr. Nash received the Wharton Healthcare Alumni Achievement Award.

Repeatedly named to Modern Healthcare's list of Most Powerful Persons in Healthcare, his national activities cover a wide scope. He served as chair of a National Quality Forum Technical Advisory Panel and is a member of the Board of Directors of The Care Continuum Alliance (formerly DMAA). Dr. Nash is a principal faculty member for quality of care programming for the American College of Physician Executives in Tampa, Florida, and is the developer of the ACPE Capstone Course on Quality. He also leads the academic joint venture between ACPE and the JSPH.

Dr. Nash is a consultant to organizations in both the public and private sectors. He has chaired the Technical Advisory Group of the Pennsylvania Health Care Cost Containment Council for a decade where he helped to pioneer public reporting of outcomes. In December 2009, he was named to the Board of Directors for Humana, Inc., one of the nation's largest publicly traded health and supplemental benefits companies. In March 2011, he joined the Board of Directors of Endo Pharmaceuticals, a publicly traded pharmaceutical company headquartered in Chadds Ford, Pennsylvania. He recently was appointed to the Board of Main Line Health, a four-hospital system in suburban Philadelphia. From 1998 to 2008, he served on the Board of Trustees of Catholic Healthcare Partners in Cincinnati, Ohio, where he chaired the Board Committee on Quality and Safety.

Through publications, public appearances, his blog, and an online column on MedPage Today, Dr. Nash reaches more than 100,000 persons every month. He has authored more than 100 articles in major journals. He has edited twenty-one books, including Connecting with the New Healthcare Consumer, The Quality Solution, Practicing Medicine in the 21st Century, Governance for Healthcare Providers Population Health: Creating a Culture of Wellness, and, most recently, Demand Better. From 1984 to 1989, he was deputy editor of Annals of Internal Medicine. Currently, he is editor-in-chief of four major national journals, including American Journal of Medical Quality, Population Health Management, P&T, and Biotechnology Healthcare.

Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College, his MD from the University of Rochester School of Medicine and Dentistry, and his MBA in health administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine-physician faculty group practice in general internal medicine.